IGF1 and breast cancer: A longer nighttime fast is associated with improved glycemic control (Lee et al., 2020), decreased breast cancer biomarkers such as leptin and insulin-like growth factor 1 (IGF-1) (Marinac et al., 2015a; Marinac et al., 2015b), and overall reduced breast cancer recurrence (Marinac et al., 2016).